Literature DB >> 9240623

The thyroid and breast cancer: a significant association?

P P Smyth.   

Abstract

The coincidence of thyroid disorders and breast cancer has long been a subject of debate. Associations with hyperthyroidism, hypothyroidism, thyroiditis and nontoxic goitre have been reported. Although no convincing evidence exists of a causal role for overt thyroid disease in breast cancer, the preponderance of published work favours an association with hypothyroidism. Geographical variations in the incidence of breast cancer have been attributed to differences in dietary iodine intake and an effect of iodide on the breast has been postulated. Recent reports have shown a direct association between thyroid enlargement, as assessed by ultrasound, and breast cancer. Although the exact mechanism for the demonstrated association between diseases of the thyroid and breast cancer remains to be elucidated, there is at least the possibility that the presence of thyroid abnormalities may influence breast cancer progression and this alone should stimulate awareness into the coincidence of the two disorders.

Entities:  

Mesh:

Year:  1997        PMID: 9240623     DOI: 10.3109/07853899708999335

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  23 in total

Review 1.  Autoimmune thyroid disease and breast cancer: a chance association?

Authors:  P P Smyth
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

2.  Hypothalamus-pituitary-thyroid axis disruption in rats with breast cancer is related to an altered endogenous oxytocin/insulin-regulated aminopeptidase (IRAP) system.

Authors:  María Pilar Carrera-González; María Jesús Ramírez-Expósito; Jose Manuel Arias de Saavedra; Rafael Sánchez-Agesta; María Dolores Mayas; Jose Manuel Martínez-Martos
Journal:  Tumour Biol       Date:  2011-01-05

Review 3.  Triiodothyronine and breast cancer.

Authors:  Maria Teresa De Sibio; Miriane de Oliveira; Fernanda Cristina Fontes Moretto; Regiane Marques Castro Olimpio; Sandro José Conde; Aline Carbonera Luvizon; Célia Regina Nogueira
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Carcinoma showing thymus-like elements of the thyroid gland: report of three cases including one case with breast cancer history.

Authors:  Guanjun Zhang; Xi Liu; Wei Huang; Xiaofeng Li; Marianne Johnstone; Yuan Deng; Yongqiang Ke; Quentin M Nunes; Hongyan Wang; Yili Wang; Xuebin Zhang
Journal:  Pathol Oncol Res       Date:  2014-11-29       Impact factor: 3.201

5.  Breast Cancer Risk in Postmenopausal Women with Medical History of Thyroid Disorder in the Women's Health Initiative.

Authors:  Chien-Hsiang Weng; Erin R Okawa; Mary B Roberts; Sue K Park; Christopher B Umbricht; JoAnn E Manson; Charles B Eaton
Journal:  Thyroid       Date:  2020-02-03       Impact factor: 6.568

6.  A case-control study of levothyroxine and the risk of colorectal cancer.

Authors:  Gad Rennert; Hedy S Rennert; Mila Pinchev; Stephen B Gruber
Journal:  J Natl Cancer Inst       Date:  2010-03-19       Impact factor: 13.506

Review 7.  Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis.

Authors:  Y Fang; L Yao; J Sun; R Yang; Y Chen; J Tian; K Yang; L Tian
Journal:  J Endocrinol Invest       Date:  2017-05-17       Impact factor: 4.256

8.  Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma.

Authors:  Nina Ditsch; Doris Mayr; Miriam Lenhard; Carolin Strauss; Andrea Vodermaier; Julia Gallwas; Doris Stoeckl; Monika Graeser; Tobias Weissenbacher; Klaus Friese; Udo Jeschke
Journal:  Oncol Lett       Date:  2012-07-13       Impact factor: 2.967

Review 9.  Thyroid hormone actions in liver cancer.

Authors:  Sheng-Ming Wu; Wan-Li Cheng; Crystal D Lin; Kwang-Huei Lin
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

10.  Hypothyroidism enhances tumor invasiveness and metastasis development.

Authors:  Olaia Martínez-Iglesias; Susana García-Silva; Javier Regadera; Ana Aranda
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.